Ocugen financials
$1.09+5.83%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M | $1.5M | — | $1.8M | $1.4M | $1.5M | $764.0K | $1.1M | $1.1M | $1.0M | $1.4M | $3.7M |
| Gross profit | $1.5M | $1.5M | — | $1.8M | $1.4M | $1.5M | $764.0K | $1.1M | $1.1M | $1.0M | $1.4M | $3.7M |
| Gross margin | 100.0% | 100.0% | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$16.4M | -$17.8M | — | -$17.6M | -$13.8M | -$14.5M | -$13.8M | -$13.3M | -$15.4M | -$12.2M | -$11.5M | -$12.4M |
| Net income | -$24.9M | -$19.2M | — | -$20.1M | -$14.7M | -$15.3M | -$13.9M | -$13.0M | -$15.3M | -$11.9M | -$11.0M | -$11.7M |
| Net margin | −1671.8% | −1250.9% | — | −1144.5% | −1073.5% | −1036.5% | −1816.8% | −1141.7% | −1339.2% | −1175.9% | −778.6% | −316.8% |
| Diluted EPS | $-0.07 | $-0.06 | — | $-0.07 | $-0.05 | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.05 | $-0.04 | $-0.05 |
| EBITDA | -$15.9M | -$17.2M | -$397.0K | -$16.7M | -$12.6M | -$13.9M | -$13.2M | -$12.6M | -$14.9M | -$12.0M | -$11.3M | -$12.3M |
| Operating cash flow | -$12.2M | -$21.8M | -$14.0M | -$12.9M | -$10.7M | -$19.4M | -$10.4M | -$11.3M | -$9.9M | -$10.6M | -$11.3M | -$13.7M |
| Free cash flow | -$12.2M | -$21.8M | -$14.0M | -$13.0M | -$10.8M | -$19.4M | -$10.4M | -$11.8M | -$10.4M | -$12.9M | -$14.0M | -$17.1M |
| Diluted shares | 338.7M | 327.5M | 312.6M | 304.0M | 292.1M | 292.0M | 291.2M | 278.2M | 257.4M | 257.2M | 257.0M | 256.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $100.1M | $31.9M | $18.6M | $32.6M | $27.0M | $37.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $84.1M | $29.2M | $28.8M | $28.4M | $28.0M | $27.7M |
| Total assets | $124.2M | $56.9M | $43.5M | $57.6M | $53.6M | $64.5M |
| Total liabilities | $140.8M | $51.1M | $55.7M | $54.1M | $50.5M | $48.5M |
| Shareholders' equity | -$16.6M | $5.8M | -$12.2M | $3.5M | $3.1M | $15.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology